Literature DB >> 21838846

Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.

Zsuzsa Szombathyne Meszaros1, Jacqueline A Dimmock, Robert J Ploutz-Snyder, Ynesse Abdul-Malak, Luba Leontieva, Kelly Canfield, Steven L Batki.   

Abstract

The goal of the present study was to identify predictors of smoking severity in patients with schizophrenia and co-occurring alcohol use disorders (AUD). Our hypothesis was that negative symptoms of schizophrenia, severity of depression, male gender, drinking severity, and recreational drug use were associated with increased smoking. Clinical data, including demographic variables, alcohol and substance use severity, psychiatric medications, severity of depression, positive and negative symptoms of schizophrenia were analyzed in a cohort of 90 patients with schizophrenia or schizoaffective disorder and AUD. Eighty-eight percent of participants were smokers, they smoked an average of 15 cigarettes/day. Zero-inflated negative binomial (ZINB) regression analyses demonstrated that alcohol use severity, gender, and severity of negative symptoms were not predictive of the number of cigarettes smoked. Smoking severity was positively related to Caucasian race, psychosis severity (Positive and Negative Syndrome Scale [PANSS] general score), and medications (conventional antipsychotics). Subjects who used recreational drugs smoked less. In summary, severe, treatment resistant schizophrenia, and conventional antipsychotic treatment is associated with heavy smoking in patients with schizophrenia and AUD regardless of gender or alcohol use. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21838846      PMCID: PMC3156655          DOI: 10.1111/j.1521-0391.2011.00150.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  30 in total

1.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

2.  Smoking behaviour as a predictor of depression among Finnish men and women: a prospective cohort study of adult twins.

Authors:  Tellervo Korhonen; Ulla Broms; Jyrki Varjonen; Kalle Romanov; Markku Koskenvuo; Taru Kinnunen; Jaakko Kaprio
Journal:  Psychol Med       Date:  2006-12-21       Impact factor: 7.723

3.  Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

Authors:  Kristi A Sacco; Angelo Termine; Aisha Seyal; Melissa M Dudas; Jennifer C Vessicchio; Suchitra Krishnan-Sarin; Peter I Jatlow; Bruce E Wexler; Tony P George
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions.

Authors:  M Carmen Aguilar; Manuel Gurpegui; Francisco J Diaz; Jose de Leon
Journal:  Br J Psychiatry       Date:  2005-03       Impact factor: 9.319

5.  Subjective effects and the main reason for smoking in outpatients with schizophrenia: a case-control study.

Authors:  Manuel Gurpegui; José M Martínez-Ortega; Dolores Jurado; M Carmen Aguilar; Francisco J Diaz; Jose de Leon
Journal:  Compr Psychiatry       Date:  2006-12-05       Impact factor: 3.735

6.  Comorbid schizophrenia and substance abuse.

Authors:  Alan I Green; E Sherwood Brown
Journal:  J Clin Psychiatry       Date:  2006-09       Impact factor: 4.384

7.  Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls.

Authors:  Jan-Erik Strand; Henrik Nybäck
Journal:  Eur Psychiatry       Date:  2005-01       Impact factor: 5.361

Review 8.  Clinical pharmacokinetics of the depot antipsychotics.

Authors:  M W Jann; L Ereshefsky; S R Saklad
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

Review 9.  Alcohol and depression.

Authors:  J S Madden
Journal:  Br J Hosp Med       Date:  1993 Sep 1-14

10.  Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences.

Authors:  Howard C Margolese; Leslie Malchy; Juan Carlos Negrete; Raymond Tempier; Kathryn Gill
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

View more
  10 in total

1.  Demographics, clinical characteristics and cognitive symptoms of heavy smokers and non-heavy smokers in Chinese male patients with chronic schizophrenia.

Authors:  Shuochi Wei; Dongmei Wang; Huixia Zhou; Luyao Xia; Yang Tian; Qilong Dai; Rongrong Zhu; Wenjia Wang; Dachun Chen; Meihong Xiu; Li Wang; Xiangyang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-26       Impact factor: 5.760

2.  Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study.

Authors:  Pierre-Michel Llorca; Philippe Nuss; Éric Fakra; Isabelle Alamome; Dominique Drapier; Wissam El Hage; Renaud Jardri; Stéphane Mouchabac; Marc Rabbani; Nicolas Simon; Marie-Noëlle Vacheron; Jean-Michel Azorin
Journal:  BMC Psychiatry       Date:  2022-05-28       Impact factor: 4.144

3.  Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population.

Authors:  Xiang Yang Zhang; Da Chun Chen; Yun Long Tan; Mei Hong Xiu; Jingyi Cui; Li Hui; Fu De Yang; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2013-08-21       Impact factor: 4.530

4.  Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study.

Authors:  Stacia M DeSantis; Dipankar Bandyopadhyay; Nathaniel L Baker; Patrick K Randall; Raymond F Anton; James J Prisciandaro
Journal:  Drug Alcohol Depend       Date:  2013-04-06       Impact factor: 4.492

5.  Clinical characteristics of heavy and non-heavy smokers with schizophrenia.

Authors:  Heidi J Wehring; Fang Liu; Robert P McMahon; Kristen M Mackowick; Raymond C Love; Lisa Dixon; Deanna L Kelly
Journal:  Schizophr Res       Date:  2012-05-10       Impact factor: 4.939

6.  Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies.

Authors:  Nicole Meade; Lily Shi; Stine R Meehan; Catherine Weiss; Zahinoor Ismail
Journal:  J Psychopharmacol       Date:  2020-07-10       Impact factor: 4.153

7.  Prevalence and smokers' profile: comparisons between the psychiatric population and the general population.

Authors:  Renata Marques de Oliveira; Jair Lício Ferreira Santos; Antonia Regina Ferreira Furegato
Journal:  Rev Lat Am Enfermagem       Date:  2019-04-29

8.  Prevalence of tobacco dependence and associated factors among patients with schizophrenia attending their treatments at southwest Ethiopia; hospital-based cross-sectional study.

Authors:  Defaru Desalegn; Zakir Abdu; Mohammedamin Hajure
Journal:  PLoS One       Date:  2021-12-15       Impact factor: 3.240

9.  Prevalence and correlates of cigarette smoking among Chinese schizophrenia inpatients receiving antipsychotic mono-therapy.

Authors:  Yan-Min Xu; Hong-Hui Chen; Fu Li; Fang Deng; Xiao-Bo Liu; Hai-Chen Yang; Li-Guo Qi; Jin-Hong Guo; Tie-Bang Liu
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

Review 10.  The Risk Factors of the Alcohol Use Disorders-Through Review of Its Comorbidities.

Authors:  Ping Yang; Rui Tao; Chengsen He; Shen Liu; Ying Wang; Xiaochu Zhang
Journal:  Front Neurosci       Date:  2018-05-11       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.